ELIXIR-UK has conceived BioFAIR, a new digital research infrastructure that enables the data and processing resources of ELIXIR and other partners to be delivered to researchers across the UK. A national BioCommons will maximise the Findability, Accessibility, Interoperability, Reusability (FAIR) and Reproducibility of life science data and data workflows.
The five-year funding of £34 million for BioFAIR is subject to business case approvals. The investment comes from UKRI’s Infrastructure Fund and the Digital Research Infrastructure (DRI) programme.
This need for BioFAIR is supported by the outcomes of a Feasibility Study commissioned to ELIXIR-UK by UKRI-BBSRC, UKRI-MRC and Wellcome Trust, and carried out with Technopolis Group. It’s possible to read the full report here.